/biz/ - Business & Finance

>>1885956

Looks like they might have a rheumatoid arthritis treatment in the works along with multikine. Preclinical so early stages yet, only animal testing done so far.

http://www.cel-sci.com/press_281leaps.html

investigational new drug candidate CEL-4000 has the potential for use as a therapeutic vaccine to treat rheumatoid arthritis. CEL-4000 has been developed using CEL-SCI's patented LEAPS (Ligand Epitope Antigen Presentation System) technology. Data were presented by Daniel Zimmerman, Ph.D., CEL-SCI's Senior Vice President of Research, Cellular Immunology, at the American College of Rheumatology's Annual Meeting in Washington DC. The poster presentation titled, "A Therapeutic Peptide Vaccine Reduces Pro-inflammatory Responses and Suppresses Arthritis in the Cartilage Proteoglycan G1 Domain-induced Mouse Model of Rheumatoid Arthritis," was presented on November 14, 2016.